TTM
$1.31
YoY change
-3.5%
5Y CAGR
-3.5%
Peak year (2022)
$5.47
Latest annual
$1.36
EPS (Diluted) history chart for Pfizer (PFE) from 1985 to 2025
Latest: $1.36
EPS (Diluted) growth chart for Pfizer (PFE) from 1985 to 2025
Latest: -3.5%
EPS (Diluted) history table for Pfizer (PFE) from 1985 to 2025
| 2025 | $1.36 | -3.5% | −$0.05 | ||
| 2024 | $1.41 | +279.8% | +$1.04 | ||
| 2023 | $0.37 | -93.2% | −$5.10 | ||
| 2022 | $5.47 | +41.0% | +$1.59 | ||
| 2021 | $3.88 | +138.6% | +$2.25 | ||
| 2020 | $1.63 | -43.3% | −$1.24 | ||
| 2019 | $2.87 | +53.7% | +$1.00 | ||
| 2018 | $1.87 | -46.9% | −$1.65 | ||
| 2017 | $3.52 | +200.6% | +$2.35 | ||
| 2016 | $1.17 | +5.1% | +$0.06 | ||
| 2015 | $1.11 | -21.2% | −$0.30 | ||
| 2014 | $1.41 | -16.3% | −$0.28 | ||
| 2013 | $1.69 | +29.6% | +$0.39 | ||
| 2012 | $1.30 | +17.8% | +$0.20 | ||
| 2011 | $1.11 | +8.4% | +$0.09 | ||
| 2010 | $1.02 | -17.1% | −$0.21 | ||
| 2009 | $1.23 | +3.5% | +$0.04 | ||
| 2008 | $1.19 | +0.5% | +$0.01 | ||
| 2007 | $1.18 | -22.2% | −$0.34 | ||
| 2006 | $1.52 | +49.0% | +$0.50 | ||
| 2005 | $1.02 | -31.5% | −$0.47 | ||
| 2004 | $1.49 | +175.9% | +$0.95 | ||
| 2003 | $0.54 | -63.0% | −$0.92 | ||
| 2002 | $1.46 | +19.7% | +$0.24 | ||
| 2001 | $1.22 | +106.8% | +$0.63 | ||
| 2000 | $0.59 | -24.4% | −$0.19 | ||
| 1999 | $0.78 | -8.2% | −$0.07 | ||
| 1998 | $0.85 | +51.8% | +$0.29 | ||
| 1997 | $0.56 | +12.0% | +$0.06 | ||
| 1996 | $0.50 | +19.0% | +$0.08 | ||
| 1995 | $0.42 | +20.0% | +$0.07 | ||
| 1994 | $0.35 | +105.9% | +$0.18 | ||
| 1993 | $0.17 | -15.0% | −$0.03 | ||
| 1992 | $0.20 | +11.1% | +$0.02 | ||
| 1991 | $0.18 | -14.3% | −$0.03 | ||
| 1990 | $0.21 | +31.2% | +$0.05 | ||
| 1989 | $0.16 | -15.8% | −$0.03 | ||
| 1988 | $0.19 | +11.8% | +$0.02 | ||
| 1987 | $0.17 | +6.3% | +$0.01 | ||
| 1986 | $0.16 | +14.3% | +$0.02 | ||
| 1985 | $0.14 | — | — |
- 2025$1.36-3.5%
- 2024$1.41+279.8%
- 2023$0.37-93.2%
- 2022$5.47+41.0%
- 2021$3.88+138.6%
- 2020$1.63-43.3%
- 2019$2.87+53.7%
- 2018$1.87-46.9%
- 2017$3.52+200.6%
- 2016$1.17+5.1%
- 2015$1.11-21.2%
- 2014$1.41-16.3%
- 2013$1.69+29.6%
- 2012$1.30+17.8%
- 2011$1.11+8.4%
- 2010$1.02-17.1%
- 2009$1.23+3.5%
- 2008$1.19+0.5%
- 2007$1.18-22.2%
- 2006$1.52+49.0%
- 2005$1.02-31.5%
- 2004$1.49+175.9%
- 2003$0.54-63.0%
- 2002$1.46+19.7%
- 2001$1.22+106.8%
- 2000$0.59-24.4%
- 1999$0.78-8.2%
- 1998$0.85+51.8%
- 1997$0.56+12.0%
- 1996$0.50+19.0%
- 1995$0.42+20.0%
- 1994$0.35+105.9%
- 1993$0.17-15.0%
- 1992$0.20+11.1%
- 1991$0.18-14.3%
- 1990$0.21+31.2%
- 1989$0.16-15.8%
- 1988$0.19+11.8%
- 1987$0.17+6.3%
- 1986$0.16+14.3%
- 1985$0.14—
EPS (Diluted) values are taken from Pfizer's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's current diluted EPS (TTM) is $1.31. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Pfizer (PFE) most recent annual diluted EPS stands at $1.36 (2025) – edged down 3.5% year-over-year.
Pfizer diluted EPS compound annual growth for the 2020–2025 (5 years) window is -3.5%, with a net decline across the window.
Pfizer diluted EPS plunged from $5.47 in 2022 to $1.36 in 2025, a 75.1% drawdown.
$5.47 stands as the all-time-high annual diluted EPS, posted in 2022, against a low of $0.14 during 1985.
Pfizer EPS (Diluted) by Year
Pfizer EPS (Diluted) 2025: $1.36
In 2025, Pfizer reported diluted EPS of $1.36, edged down 3.5% below 2024.
Pfizer EPS (Diluted) 2024: $1.41
Pfizer diluted EPS in 2024 was $1.41, surged 279.8% from 2023.
Pfizer EPS (Diluted) 2023: $0.37
2023's diluted EPS for Pfizer came in at $0.37, plunged 93.2% below 2022.
Pfizer EPS (Diluted) 2022: $5.47
Pfizer posted diluted EPS of $5.47 in 2022, surged 41.0% from 2021. This figure represents the highest annual value in the available history.
Pfizer EPS (Diluted) 2021: $3.88
Pfizer diluted EPS in 2021 was $3.88.
See more financial history for Pfizer (PFE). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Pfizer (PFE), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation